New AMR Report Is ‘A Wake-Up Call’, Says Industry Body
Low Investment, Lack Of Incentives Seen As Key Problems
Another day, another report on how to tackle the ever-present problem of antimicrobial resistance and the dearth of new treatment. In its latest assessment of the state of play, the AMR Industry Alliance has come up with some alarming facts and figures – and some ideas for the next steps.
